ReviewOncoTargets and therapy2014
Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma.
Ding-Wei Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled ittrialcites it